MKI67 and neoplasm: To the best of our knowledge, SHIDC-B-Ki-67 is the first benchmark introducing IHC marked breast cancer specimens that has cell annotations in three different classes of immunopositive, immuno negative, and tumor infiltrating lymphocytes.